SNG Insider Trading

Insider Ownership Percentage: 3.32%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

Synairgen Insider Trading History Chart

This chart shows the insider buying and selling history at Synairgen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Synairgen Share Price & Price History

Current Price: GBX 5.10
Price Change: Price Decrease of -0.035 (-0.68%)
As of 03/28/2024 08:40 PM ET

This chart shows the closing price history over time for SNG up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Synairgen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2022Bruce CampbellInsiderBuy621GBX 189£1,173.69
8/12/2021John C WardInsiderSell269,963GBX 140£377,948.20
See Full Table

SEC Filings (Institutional Ownership Changes) for Synairgen (LON:SNG)

28.79% of Synairgen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Synairgen logo
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
Read More on Synairgen

Today's Range

Now: GBX 5.10
Low: 4.68
High: 5.90

50 Day Range

MA: GBX 5.27
Low: 4.50
High: 6.27

52 Week Range

Now: GBX 5.10
Low: 4
High: 17.50

Volume

180,475 shs

Average Volume

299,406 shs

Market Capitalization

£10.26 million

P/E Ratio

N/A

Dividend Yield

1.53%

Beta

N/A